Steven Smith
Overview
Explore the profile of Steven Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1826
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith S, Rayner J, Kim J
Microbiol Spectr
. 2025 Jan;
13(3):e0268924.
PMID: 39868868
Importance: Monitoring viral infections in living animals is a valuable approach for understanding how viruses replicate and cause disease. This study focuses on bioluminescent influenza A virus infection in a...
2.
Hayanga H, Rosenblum A, McGuire J, Noor K, Thibault D, Woods K, et al.
Disaster Med Public Health Prep
. 2025 Jan;
19():e13.
PMID: 39791325
Objectives: This study sought to assess undergraduate students' knowledge and attitudes surrounding perceived self-efficacy and threats in various common emergencies in communities of higher education. Methods: Self-reported perceptions of knowledge...
3.
Schlessinger J, Bennet R, Coakwell J, Smith S, Kao E
Sci Rep
. 2025 Jan;
15(1):1110.
PMID: 39774624
Reporting by major media outlets influences news coverage by other outlets, resulting in an outsized impact on public opinion. Understanding this inter-outlet influence, known as intermedia agenda setting, is important...
4.
Al-Hamdani M, Davidson M, Smith S
J Addict Dis
. 2024 Dec;
:1-8.
PMID: 39696808
Objectives: To examine whether various quit strategies and relapse triggers are associated with maintenance period in a sample of people who quit vaping. Method: Young Canadians who used to vape...
5.
Hannestad J, Smith S, Lam A, Hurt J, Harada N, Kim R, et al.
Clin Transl Sci
. 2024 Nov;
17(11):e70064.
PMID: 39535924
TQS-168, a first-in-class small-molecule inducer of peroxisome proliferator-activated receptor gamma coactivator 1-alpha gene expression, is in development for the treatment of amyotrophic lateral sclerosis. A single-ascending-dose (SAD) and multiple-ascending-dose (MAD)...
6.
Huang W, Ahmed M, Morris E, Yang L, ONeal L, Hernandez I, et al.
JACC Adv
. 2024 Aug;
3(7):100958.
PMID: 39129974
Background: Sacubitril/valsartan, an angiotensin receptor/neprilysin inhibitor (ARNi), improves heart failure (HF) outcomes, yet real-world adherence patterns are not well understood. Objectives: The purpose of this study was to analyze longitudinal...
7.
Rupani H, Edwards D, Chaudhuri R, Smith S, Jackson D, Hearn A, et al.
J Allergy Clin Immunol Pract
. 2024 May;
12(9):2510-2513.e2.
PMID: 38796102
No abstract available.
8.
Nussbaum J, Hussain A, Butera P, Ford A, Kitt M, ONeill E, et al.
J Clin Pharmacol
. 2024 Apr;
64(8):1023-1029.
PMID: 38651193
Gefapixant (MK-7264, RO4926219, AF-219) is a first-in-class P2X3 antagonists being developed to treat refractory or unexplained chronic cough. The initial single- and multiple-dose safety, tolerability, and pharmacokinetics of gefapixant at...
9.
Yarchoan M, Powderly J, Bastos B, Karasic T, Crysler O, Munster P, et al.
Cancer Res Commun
. 2024 Mar;
4(4):1100-1110.
PMID: 38551394
Purpose: TPST-1120 is a first-in-class oral inhibitor of peroxisome proliferator-activated receptor α (PPARα), a fatty acid ligand-activated transcription factor that regulates genes involved in fatty acid oxidation, angiogenesis, and inflammation,...
10.
Poklepovic A, Gordon S, Kothadia S, McGuire W, Thacker L, Deng X, et al.
Anticancer Drugs
. 2024 Mar;
35(5):450-458.
PMID: 38452059
The purpose of this study is to establish the recommended phase 2 dose for regorafenib in combination with sildenafil for patients with advanced solid tumors. Secondary outcomes included identification of...